Transcutaneous cervical vagus nerve stimulation reduces behavioral and physiological manifestations of withdrawal in patients with opioid use disorder: A double-blind, randomized, sham-controlled pilot study

Drug Overdose Deaths in the U.S. Top 100,000 Annually [Internet]. [cited 2022 Feb 25]. Available from:: https://www.cdc.gov/nchs/pressroom/nchs_press_releases/2021/20211117.htm. Bailey, 2013, Perceived relapse risk and desire for medication assisted treatment among persons seeking inpatient opiate detoxification, J Subst Abuse Treat, 45, 302, 10.1016/j.jsat.2013.04.002 Sigmon, 2012, Opioid detoxification and naltrexone induction strategies: recommendations for clinical practice, Am J Drug Alcohol Abuse, 38, 187, 10.3109/00952990.2011.653426 Volkow, 2014, Medication-assisted therapies — tackling the opioid-overdose epidemic, N Engl J Med, 370, 2063, 10.1056/NEJMp1402780 Beetham, 2019, Access to office-based buprenorphine treatment in areas with high rates of opioid-related mortality: an audit study, Ann Intern Med, 171, 1, 10.7326/M18-3457 Bell, 2020, Medication treatment of opioid use disorder, Biol Psychiatr, 87, 82, 10.1016/j.biopsych.2019.06.020 Lagisetty, 2019, Role of an accurate treatment locator and cash-only practices in access to buprenorphine for opioid use disorders, Ann Intern Med, 171, 58, 10.7326/M19-1429 Mattick, 2002, Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence, Cochrane Database Syst Rev, CD002209 Krupitsky, 2011, Injectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomised trial, Lancet (London, England), 377, 1506, 10.1016/S0140-6736(11)60358-9 Tanum, 2017, Effectiveness of injectable extended-release naltrexone vs daily buprenorphine-naloxone for opioid dependence: a randomized clinical noninferiority trial, JAMA Psychiatr, 74, 1197, 10.1001/jamapsychiatry.2017.3206 Lee, 2016, Extended-Release naltrexone to prevent opioid relapse in criminal justice offenders, N Engl J Med, 374, 1232, 10.1056/NEJMoa1505409 Strang, 2003, Loss of tolerance and overdose mortality after inpatient opiate detoxification: follow up study, BMJ Br Med J (Clin Res Ed), 326, 959, 10.1136/bmj.326.7396.959 Sullivan, 2017, Long-acting injectable naltrexone induction: a randomized trial of outpatient opioid detoxification with naltrexone versus buprenorphine, Am J Psychiatr, 174, 459, 10.1176/appi.ajp.2016.16050548 Zagorski N. FDA clears way for stimulation device to treat opioid withdrawal symptoms. https://doi.org/101176/appi.pn20181a16. 2017 Dec 26;53(1):1–1. Miranda A, Taca A. Neuromodulation with percutaneous electrical nerve field stimulation is associated with reduction in signs and symptoms of opioid withdrawal: a multisite, retrospective assessment. https://doi.org/101080/0095299020171295459. 2017 Jan 2;44(1):56–63. Gurel, 2020, Quantifying acute physiological biomarkers of transcutaneous cervical vagal nerve stimulation in the context of psychological stress, Brain Stimul, 13, 47, 10.1016/j.brs.2019.08.002 Gurel, 2020, Transcutaneous cervical vagal nerve stimulation reduces sympathetic responses to stress in posttraumatic stress disorder: a double-blind, randomized, sham controlled trial, Neurobiol Stress, 13 Gazi, 2020, Digital cardiovascular biomarker responses to transcutaneous cervical vagus nerve stimulation: state-space modeling, prediction, and simulation, JMIR mHealth uHealth, 8, 10.2196/20488 Gazi, 2021, Transcutaneous cervical vagus nerve stimulation lengthens exhalation in the context of traumatic stress, 1 Gazi, 2021, Transcutaneous cervical vagus nerve stimulation inhibits the reciprocal of the pulse transit time's responses to traumatic stress in posttraumatic stress disorder, 1444 Bremner, 2020, Transcutaneous vagal nerve stimulation blocks stress-induced activation of Interleukin-6 and interferon-γ in posttraumatic stress disorder: a double-blind, randomized, sham-controlled trial, Brain, Behav Immun - Heal, 9 Bremner, 2020, Application of noninvasive vagal nerve stimulation to stress-related psychiatric disorders, J Personalized Med, 10, 1 Koob, 2020, Neurobiology of opioid addiction: opponent process, hyperkatifeia, and negative reinforcement, Biol Psychiatr, 87, 44, 10.1016/j.biopsych.2019.05.023 Wittbrodt, 2021, Noninvasive cervical vagal nerve stimulation alters brain activity during traumatic stress in individuals with posttraumatic stress disorder, Psychosom Med, 83, 969, 10.1097/PSY.0000000000000987 Wittbrodt, 2020, Non-invasive vagal nerve stimulation decreases brain activity during trauma scripts, Brain Stimul, 13, 1333, 10.1016/j.brs.2020.07.002 Back, 2014, Laboratory-induced cue reactivity among individuals with prescription opioid dependence, Addict Behav, 39, 1217, 10.1016/j.addbeh.2014.04.007 Wesson, 2003, The clinical opiate withdrawal scale (COWS), J Psychoact Drugs, 35, 253, 10.1080/02791072.2003.10400007 Mantsch, 2015, Stress-induced reinstatement of drug seeking: 20 Years of progress, Neuropsychopharmacology, 41, 335, 10.1038/npp.2015.142 Sinha, 2001, How does stress increase risk of drug abuse and relapse?, Psychopharmacol, 158, 343, 10.1007/s002130100917 Wolpe, 1966 Gazi, 2022, Robust estimation of respiratory variability uncovers correlates of limbic brain activity and transcutaneous cervical vagus nerve stimulation in the context of traumatic stress, IEEE Trans Biomed Eng, 69, 10.1109/TBME.2021.3108135 Bailey, 2013, Perceived relapse risk and desire for medication assisted treatment among persons seeking inpatient opiate detoxification, J Subst Abuse Treat, 45, 302, 10.1016/j.jsat.2013.04.002 Cicero, 2017, The prescription opioid epidemic: a review of qualitative studies on the progression from initial use to abuse, Dialogues Clin Neurosci, 19, 259, 10.31887/DCNS.2017.19.3/tcicero Rigg, 2010, Motivations for non-medical prescription drug use: a mixed methods analysis, J Subst Abuse Treat, 39, 236, 10.1016/j.jsat.2010.06.004 Kosten, 2019, Review article: effective management of opioid withdrawal symptoms: a gateway to opioid dependence treatment, Am J Addict, 28, 55, 10.1111/ajad.12862 Pergolizzi, 2020, Opioid withdrawal symptoms, a consequence of chronic opioid use and opioid use disorder: current understanding and approaches to management, J Clin Pharm Therapeut, 45, 892 Shah, 2019, Characteristics of initial prescription episodes and likelihood of long-term opioid use — United States, 2006–2015, MMWR Morb Mortal Wkly Rep, 66, 265, 10.15585/mmwr.mm6610a1 Compton, 2001, Pain intolerance in opioid-maintained former opiate addicts: effect of long-acting maintenance agent, Drug Alcohol Depend, 63, 139, 10.1016/S0376-8716(00)00200-3 Bommersbach, 2020, Perpetual hunger: the neurobiological consequences of long-term opioid use, Biol Psychiatr, 87, e1, 10.1016/j.biopsych.2019.10.007 Sinha, 2008, Chronic stress, drug use, and vulnerability to addiction, Ann N Y Acad Sci, 1141, 105, 10.1196/annals.1441.030 Stewart, 2000, Pathways to relapse: the neurobiology of drug- and stress-induced relapse to drug-taking, J Psychiatry Neurosci, 25, 125 Koob, 2020, Neurobiology of opioid addiction: opponent process, hyperkatifeia, and negative reinforcement, Biol Psychiatr, 87, 44, 10.1016/j.biopsych.2019.05.023 Koob, 2009, Neurocircuitry of addiction, Neuropsychopharmacology, 35, 217, 10.1038/npp.2009.110 Godoy, 2018, A comprehensive overview on stress neurobiology: basic concepts and clinical implications, Front Behav Neurosci, 12, 127, 10.3389/fnbeh.2018.00127 Klabunde, 2011 McCorry, 2007, Physiology of the autonomic nervous system, Am J Pharmaceut Educ, 71 Ziegler, 2004, Psychological stress and the autonomic nervous system, 189 Organization, 2009 Comer, 2006, Injectable, sustained-release naltrexone for the treatment of opioid dependence: a randomized, placebo-controlled trial, Arch Gen Psychiatr, 63, 210, 10.1001/archpsyc.63.2.210 Redgrave, 2018, Safety and tolerability of Transcutaneous Vagus Nerve stimulation in humans; a systematic review, Brain Stimul, 11, 1225, 10.1016/j.brs.2018.08.010 Pergolizzi, 2019, The role of lofexidine in management of opioid withdrawal, Pain Ther, 8, 67, 10.1007/s40122-018-0108-7 Young JR, Smani SA, Mischel NA, Kritzer MD, Appelbaum LG, Patkar AA. Non-invasive brain stimulation modalities for the treatment and prevention of opioid use disorder: a systematic review of the literature. https://doi.org/101080/1055088720201736756. 2020 Feb 17;38(2):186–99.